A case report details the failure of a novel dual-device strategy involving the PRESERFLO MicroShunt connected to an Ahmed ClearPath. This study contributes to the understanding of device interactions in glaucoma treatment.

A case study highlights delayed-onset giant bleb formation and persistent intraocular pressure elevation in a patient with COVID-19 who had a long-term Ahmed glaucoma valve. This finding may have implications for managing glaucoma in patients with COVID-19.

Research demonstrates that 4-phenylbutyric acid-loaded mesoporous silica nanoparticles can alleviate endoplasmic reticulum stress and reduce intraocular pressure in a glaucoma model. This study highlights a potential therapeutic approach for managing glaucoma-related complications.

Eli Lilly showcased its advancements in the metabolic space at the American Diabetes Association meeting, highlighting the new pill Foundayo and the next-generation asset retatrutide for indications including menopause and sleep apnea. This reinforces Lilly's strong position in the weight loss market.

Oculis SA and European Biotech Acquisition Corp. have announced a business combination to advance product candidates targeting significant medical needs in ophthalmology, including diabetic macular edema and dry eye disease. Notably, OCS-05, a potential treatment for acute optic neuritis, is in development to address this rare disease with no current approved therapies.